Rate My Professor Gayle Ross

GR

Gayle Ross

University of Melbourne

4.40/5 · 5 reviews
5 Star2
4 Star3
3 Star0
2 Star0
1 Star0
4.08/20/2025

Creates a safe space for learning and growth.

4.05/21/2025

Encourages creative and innovative thinking.

5.03/31/2025

Encourages students to think critically.

4.02/27/2025

Creates a positive and welcoming vibe.

5.02/4/2025

Great Professor!

About Gayle

Associate Professor Gayle Ross is a dermatologist serving as Associate Professor in Dermatology Research at the Royal Melbourne Hospital (RMH) within the Department of Medicine, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne. She holds an MBBS (Hons) and is a Fellow of the Australasian College of Dermatologists (FACD). Ross has worked at RMH since 2007, where she heads Dermatology Research at both RMH and the University of Melbourne. She leads the Atopic Dermatitis Clinic and the Multidisciplinary Porphyria Service, supervises training for RMH dermatology trainees, and has previously served as Director of Training and a National Training Committee member for the Australasian College of Dermatologists. As a consultant dermatologist, she contributes to clinical care and education in medical dermatology.

Ross's academic interests center on inflammatory skin diseases, including atopic dermatitis and porphyria, genetic skin diseases, and related conditions. She has acted as an investigator on approximately 25 pharmaceutical-sponsored clinical trials focused on inflammatory skin disease and 12 investigator-led research projects. Her key publications include 'Epidemiology and impact of childhood molluscum contagiosum: a case series and critical review of the literature' (Pediatric Dermatology, 2005), 'Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo' (Clinical & Experimental Dermatology, 2017), 'Actinic prurigo' (Photodermatology, Photoimmunology & Photomedicine, 2008), 'Efficacy and safety of givosiran for acute hepatic porphyria: final results of the randomized phase III ENVISION trial' (Journal of Hepatology, 2023), and 'Upadacitinib Drug Survival in the Management of Patients With Moderate to Severe Atopic Dermatitis: Real-Time Data From the Biogrid Database Registry' (Australasian Journal of Dermatology, 2025). With over 734 citations documented on Google Scholar, her contributions have advanced understanding and treatment of dermatological conditions.

Professional Email: gayle.ross@unimelb.edu.au

    Rate My Professor: Gayle Ross | University of Melbourne | AcademicJobs